Prevention of VTE in Orthopedic Surgery Patients
Yngve Falck–Ytter(VA Northeast Ohio Healthcare System), Clifford W. Colwell(Scripps Health), Stephen G. Pauker(Tufts Medical Center), Norman A. Johanson(Cornell University), Ola E. Dahl(Innlandet Hospital Trust), Catherine Curley(MetroHealth Medical Center), Thomas L. Ortel(Duke University), Charles W. Francis(University of Rochester Medical Center), Sam Schulman(Thrombosis and Atherosclerosis Research Institute)
Cited by 1,903
Related Papers
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
|Journal of Thrombosis and Haemostasis|2005|4.9k
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
|Journal of Thrombosis and Haemostasis|2009|3.8k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Prevention of VTE in Nonsurgical Patients
|CHEST Journal|2012|2.7k
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
|New England Journal of Medicine|2009|2.6k